Main Menu Jump to Page


Retainer Agreement
info@rosenlegal.com

Global Blood shareholders have an opportunity to recover their investment losses.

Click "Join this Class Action" above.

Attorneys

Global Blood Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Global Blood Therapeutics, Inc. (NASDAQ: GBT) resulting from allegations that Global Blood may have issued materially misleading business information to the investing public.

If you purchased shares of Global Blood and would like to join the action, please click "Join this Class Action," above. 

Press Release

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Global Blood Therapeutics, Inc. – GBT

New York, N.Y., September 13, 2018. Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Global Blood Therapeutics, Inc. (NASDAQ: GBT) resulting from allegations that Global Blood may have issued materially misleading business information to the investing public.

On September 13, 2018, Stat published an article describing “important risks that investors might be glossing over” regarding Global Blood’s FDA approval prospects for its new drug to treat sickle cell disease, voxelotor. The article cited the results of a recent Phase 3 clinical trial and stated “Global Blood lacks data demonstrating voxelotor reduces the frequency of crises,” which is traditionally a necessary criterion for FDA approval of a sickle cell disease treatment. The article further stated that, “[i]n the Phase 3 study, voxelotor did not improve the quality of life of sickle cell patients.” On this news, Global Blood’s share price fell $3.40 per share or over 7.4% to close at $42.55 per share on September 13, 2018.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Global Blood investors. If you purchased shares of Global Blood please visit the firm’s website at http://www.rosenlegal.com/cases-1414.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Zachary Halper, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      zhalper@rosenlegal.com
      www.rosenlegal.com